NMG
GILD icon

New Millennium Group’s Gilead Sciences GILD Stock Holding History

New Millennium Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7
Closed -$647 – 540
2024
Q4 		$647 Buy
+7
New +$630 ﹤0.01% 506
2024
Q1 		– Sell
-32
Closed -$2.57K – 192
2023
Q4 		$2.57K Buy
32
+1
+3% +$78 ﹤0.01% 296
2023
Q3 		$2.35K Hold
31
– – ﹤0.01% 267
2023
Q2 		$2.4K Sell
31
-9
-23% -$718 ﹤0.01% 284
2023
Q1 		$3.3K Sell
40
-69
-63% -$5.71K ﹤0.01% 264
2022
Q4 		$9.31K Sell
109
-25
-19% -$1.98K 0.01% 199
2022
Q3 		$8K Buy
134
+1
+0.8% +$63 0.01% 202
2022
Q2 		$8K Buy
+133
New +$8.23K 0.01% 206

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

New Millennium Group's GILD Position: Q1 2025 in Review

New Millennium Group sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 7 shares — an estimated $647 sold.

New Millennium Group first reported a position in GILD in Q2 2022 and held it in 8 quarters. The position peaked at $9.31K in Q4 2022. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • New Millennium Group reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • New Millennium Group sold 7 Gilead Sciences shares in Q1 2025, an estimated $647.
  • New Millennium Group first reported a position in Gilead Sciences in Q2 2022 and held it in 8 quarters.
  • New Millennium Group's Gilead Sciences position peaked at $9.31K in Q4 2022.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on New Millennium Group's 13F filing for Q1 2025, filed 25 Apr 2025.